Accommodates a greater variety of patients and provides a more complete look at every patient’s heart with enhanced scanning capabilities, including a 76 percent increase in field-of-view volume[i] Leverages GE Healthcare’s exclusive Alcyone technology, which can view cardiac anatomy and pathology with great clarity and speed Introduces several new automated […]
Other News
FDA Approval and First Implant of Orsiro Mission Drug-Eluting Stent System in the U.S.
Full Commercial Launch Underway for One of the Most Studied and Thinnest Strut Drug-Eluting Stents, Offering Enhanced Deliverability LAKE OSWEGO, Ore., Sept. 29, 2021 /PRNewswire/ — BIOTRONIK announced today it received U.S. Food and Drug Administration (FDA) approval of its Orsiro® Mission bioabsorbable polymer drug-eluting stent system (BP-DES). The company also announced the first U.S. […]
Dr. Willcox Presents Study at Heart Rhythm Society: When Reviewing Heart Monitor Data, Human Technicians Outperform Artificial Intelligence by Over 200 Percent
ANCHORAGE, Alaska, Sept. 28, 2021 /PRNewswire/ — A pilot study led by Alaska Heart & Vascular Institute’s (AHVI) electrophysiologist Mark E. Willcox, MD, found that human-led diagnostic data interpretation outperformed artificiual intelligence (AI) screenings by over 200 percent. As a study initially designed to compare the performance of two common cardiac monitors—the BioGuardian by […]
Heart Experts Call For Millions To Benefit From Life-Saving Online Services As Telemedicine Rockets
– Cardiovascular disease (CVD) remains world’s biggest killer, claiming 18.6 million lives per year GENEVA, Sept. 28, 2021 /PRNewswire/ — On World Heart Day, 29 September 2021, the World Heart Federation (WHF) is calling on the international community to bring digital cardiovascular health services to millions worldwide. COVID-19 has seen an explosion in telemedicine, […]
JanOne Encouraged By Recent FDA Communications Regarding Phase 2B Clinical Trial Design of Lead Drug Candidate JAN101
JanOne’s management is encouraged regarding Recent Discussions on Potential Phase 2b Trial Endpoints and Possible Regulatory Routes for JAN101 as Treatment for Peripheral Artery Disease (PAD) LAS VEGAS, Sept. 28, 2021 /PRNewswire/ — JanOne Inc. (Nasdaq: JAN), a company that focuses on the development of treatments for conditions that cause severe pain – in […]
UPDATED: CARDIOGENICS HOLDINGS INC. ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTION
Caledon, Ontario, Sept. 28, 2021 (GLOBE NEWSWIRE) — CardioGenics Holdings INC. (OTC PINK: CGNH) announced on September 3, 2021 a record date of September 13, 2021 for its dividend distribution of 22.5 million shares of Covidgenic, a private Canadian company. The new record date for the distribution of the Covidgenic […]
Cleerly Expands Executive Team With Appointment of New Chief Operating Officer and Chief Technology Officer
Brandon Atkinson joins as COO and Nick Nieslanik as CTO to Support Company’s Mission to Create a New Standard of Care for Heart Disease, the Leading Cause of Death. NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced today it has appointed Brandon Atkinson […]
Surmodics Announces Successful First Patient Uses of Sublime™ Radial Access .018 RX PTA Dilatation Catheter
Latest addition to the Sublime™ Radial Access Platform expands market opportunity by increasing size offering to treat larger vessels and providing the shaft length needed to treat more distal lesions using a radial approach EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic […]
AstraZeneca Healthcare Foundation Awards Seven US Nonprofits More Than $900k to Improve Heart Health and Advance Health Equity
WILMINGTON, Del.–(BUSINESS WIRE)–Today on World Heart Day, the AstraZeneca HealthCare Foundation has awarded seven innovative, community-based nonprofit organizations $954,311 in grants across seven US states to address cardiovascular disease, a leading cause of death in the nation. The grants are part of the Foundation’s signature Connections for Cardiovascular HealthSM (CCH) Next Generation program, now in […]
FDA Clears Caretaker Medical’s Wireless Platform for Continuous Noninvasive Blood Pressure and Hemodynamic Monitoring
Innovative Next-Generation Technology Monitors the Most Important Vital Signs for Cardiovascular Health CHARLOTTESVILLE, Va.–(BUSINESS WIRE)–Caretaker Medical, a pioneer in wireless “beat by beat” continuous, non-invasive, advanced patient monitoring, today announced U.S. Food and Drug Administration (FDA) clearance of the company’s next-generation VitalStream™ wireless blood pressure and hemodynamic monitoring platform. Continuous […]



